Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol-Myers Squibb, Celgene shareholders vote to back proposed $74-billion merger

firstwordpharmaApril 14, 2019

Tag: Bristol-Myers Squibb , Celgene , merger

PharmaSources Customer Service